头颈癌预防性吞咽治疗:三臂随机平行组试验
该三臂随机平行组试验纳入79例接受放化疗的口咽鳞癌患者,比较临床医生面对面、远程SwallowIT和患者自我导向三种预防性吞咽治疗模式。
要点
- 三种预防性吞咽治疗模式在放化疗期间及后3个月临床结局等效。
- 所有组治疗依从性在放化疗期间均下降。
核心结论
- SwallowIT远程预防性吞咽治疗提供与传统医生面对面模式临床等效的结局。
- SwallowIT和医生主导治疗因支持水平更高而更受患者偏好。
研究设计与样本
- 三臂随机平行组试验,纳入79例接受放化疗的口咽鳞癌患者。
- 随机分为医生面对面治疗组(n=26)、SwallowIT远程治疗组(n=26)和自我导向治疗组(n=27)。
- 在基线、放化疗后6周和3个月比较吞咽、营养和功能状态,治疗后收集患者服务偏好。
主要发现
- 服务提供模式对临床结局无影响,吞咽、营养或功能指标均无显著组间差异或组×时间交互(P>.05)。
- 所有组治疗依从性在放化疗期间均下降。
- SwallowIT和医生主导模式被显著更多患者偏好(P=.002)。
临床怎么用
- SwallowIT远程模式可作为传统医生面对面预防性吞咽治疗的等效替代服务模式。
- 选择服务模式时需考虑患者偏好及治疗支持水平。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intensive prophylactic swallowing therapy can mitigate dysphagia in patients with oropharyngeal (OP) SCC, however, presents service challenges. This trial investigated the clinical efficacy of three service models delivering prophylactic swallowing therapy during (chemo)radiotherapy ([C]RT). METHODS: Patients (n = 79) with OPSCC receiving (C)RT were were randomized to: (a) clinician-directed face-to-face therapy (n = 26); (b) telepractice therapy via "SwallowIT" (n = 26); or (c) patient self-directed therapy (n = 27). Swallowing, nutritional, and functional status were compared at baseline, 6-weeks, and 3-months post-(C)RT. Patients' perceptions/preferences for service-delivery were collated posttreatment. RESULTS: Service-delivery mode did not affect clinical outcomes, with no significant (P > .05) between-group differences or group-by-time interactions observed for swallowing, nutrition, or functional measures. Therapy adherence declined during (C)RT in all groups. SwallowIT and clinician-directed models were preferred by significantly (P = .002) more patients than patient-directed. CONCLUSIONS: SwallowIT provided clinically equivalent outcomes to traditional service models. SwallowIT and clinician-directed therapy were preferred by patients, likely due to higher levels of therapy support.
引用
- Wall LR, Ward EC, Cartmill B, et al. Prophylactic swallowing therapy for patients with head and neck cancer: A three-arm randomized parallel-group trial. Head Neck. 2020. PMID: 31903689. doi:10.1002/hed.26060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。